Today’s robots invite both passive and active observers into our homes and leave our data exposed to bad actors. The bar is ...
The Lung Cancer Research Foundation® (LCRF) recently awarded five new research grants in the following areas: three LCRF ...
GSK has secured approval in Japan for Exdensur (depemokimab), the country’s first ultra-long-acting biologic for severe asthma and chronic rhinosinusitis with nasal polyps. Approved by Japan’s ...